Schulungsreihe pDL Inhalativa: Forspiro

This video explains the correct handling of the Forspiro dry powder inhaler and its special features for healthcare professionals. It demonstrates, in particular, how to instruct patients. To raise awareness of potential and especially relevant sources of error when using this device, these are presented within the context of patient training. A simplified procedure for administering the service is shown. For the recommended procedure, please refer to the information on the pDL Campus website under pDL Inhalativa. The video was produced with the utmost care to ensure that the handling is demonstrated correctly. Adapt the instructions to the individual knowledge and needs of your patients. . ... 0:00 Intro 0:47 Introduction 1:17 Demonstration of the correct inhalation technique 3:21 Practicing inhalation with typical user errors 6:08 Key points of the consultation 6:44 Additional consultation notes 8:53 Outro Device type: Blister-based dry powder inhaler Mechanism: • Drug doses are individually packaged in a band-shaped blister for each actuation • Aerosol generation through a combination of device resistance and the shear forces of forced inspiration Inhalation technique: • Smooth, forceful inhalation • The device's resistance necessitates a moderate breath strength Key messages of the consultation: • The core of the breathing maneuver is smooth, forceful inhalation followed by a 5-10 second pause • Sensitize patients who regularly use a dry powder inhaler and a DPI to the different inhalation maneuver • Regularly empty the blister pack Blister pack • Avoid covering the air vents during inhalation Available preparations: Forspiro is available with different active ingredients on the German market: • Airbufo Forspiro – Budesonide + Formoterol (glucocorticoid + long-acting β2-sympathomimetic) • Airflusal Forspiro – Salmeterol + Fluticasone 17-propionate (long-acting β2-sympathomimetic + glucocorticoid) The active ingredients in Forspiro inhalers are for long-term therapy and not suitable for the acute treatment of an attack of shortness of breath. Further links: Materials and information on the administration of pDL inhalers: https://www.abda.de/pharmazeutische-d... pDL Campus live! continuing education series: https://www.pdlcampus-live.de/pdl/liv... Sources: German Respiratory League: Inhalation with Forspiro; last accessed on April 16, 2026 at: https://www.atemwegsliga.de/forspiro.... Hexal AG (as of September 2021): Patient Information Leaflet: Information for users; Airbufo® Forspiro® 160 micrograms/4.5 micrograms, single-dose powder for inhalation; last accessed on April 16, 2026 at: https://www.apotheken-umschau.de/medi... Hexal AG (as of January 2021): Patient Information Leaflet: Information for users; Airflusal® Forspiro® 50 micrograms/500 micrograms/dose single-dose powder for inhalation; last accessed on April 16, 2026 at: https://www.apotheken-umschau.de/medi... Jeaschke, Robert/Spindler, Thomas: Inhalativa. Stuttgart: Deutscher Apotheker Verlag 2023. Kircher W. Arzneiformen richtig Anwendungsanwendung: Sachgerechte Gebrauch und Lagerung der Arzneimittel. 4th, completely revised edition. Stuttgart: Deutscher Apotheker Verlag 2016. © BAK – Bundesapothekerkammer Status: April 2026